Morepen Labs.

26
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
42.57
-0.88 (-2.03%)
BSENSE

Dec 05

BSE+NSE Vol: 9.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
1,811.00
1,690.00
1,417.00
1,546.00
1,188.00
853.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,811.00
1,690.00
1,417.00
1,546.00
1,188.00
853.00
Expenditure (Ex Depriciation)
Stock Adjustments
-47.00
2.00
16.00
-10.00
-41.00
-10.00
Raw Materials Consumed
1,206.00
1,060.00
939.00
1,059.00
822.00
567.00
Power & Fuel Cost
40.00
34.00
23.00
18.00
13.00
12.00
Employee Cost
208.00
181.00
154.00
164.00
135.00
109.00
Operating Expenses
50.00
41.00
22.00
18.00
10.00
8.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
79.00
109.00
66.00
53.00
49.00
40.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
25.00
27.00
46.00
51.00
34.00
12.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,637.00
1,531.00
1,337.00
1,410.00
1,069.00
784.00
Operating Profit (PBDIT) excl Other Income
174.00
158.00
79.00
136.00
118.00
68.00
Other Income
18.00
13.00
6.00
10.00
12.00
9.00
Operating Profit (PBDIT)
192.00
172.00
85.00
146.00
130.00
77.00
Interest
8.00
3.00
1.00
-7.00
1.00
1.00
Profit before Depriciation and Tax
184.00
168.00
83.00
154.00
128.00
76.00
Depreciation
28.00
33.00
27.00
27.00
30.00
36.00
Profit Before Taxation & Exceptional Items
155.00
135.00
55.00
126.00
98.00
39.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
155.00
135.00
55.00
126.00
98.00
39.00
Provision for Tax
37.00
38.00
17.00
25.00
1.00
5.00
Profit After Tax
118.00
96.00
38.00
101.00
97.00
33.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
286.00
190.00
151.00
54.00
-42.00
-76.00
Profit Available for appropriations
404.00
286.00
190.00
156.00
54.00
-42.00
Appropriations
404.00
286.00
190.00
156.00
54.00
-42.00
Equity Dividend (%)
10.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
2.20
1.88
0.77
2.26
2.16
0.75
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.17% vs 19.25% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 9.74% vs 99.44% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 124.86% vs 87.31% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 22.14% vs 149.82% in Mar 2024

Compare Profit and Loss Results of Morepen Labs.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,811.00
1,664.00
147.00
8.83%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,811.00
1,664.00
147.00
8.83%
Expenditure (Ex Depriciation)
Stock Adjustments
-47.00
-39.00
-8.00
-20.51%
Raw Materials Consumed
1,206.00
537.00
669.00
124.58%
Power & Fuel Cost
40.00
59.00
-19.00
-32.20%
Employee Cost
208.00
394.00
-186.00
-47.21%
Operating Expenses
50.00
110.00
-60.00
-54.55%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
79.00
222.00
-143.00
-64.41%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
25.00
57.00
-32.00
-56.14%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,637.00
1,565.00
72.00
4.60%
Operating Profit (PBDIT) excl Other Income
174.00
99.00
75.00
75.76%
Other Income
18.00
5.00
13.00
260.00%
Operating Profit (PBDIT)
192.00
104.00
88.00
84.62%
Interest
8.00
66.00
-58.00
-87.88%
Profit before Depriciation and Tax
184.00
38.00
146.00
384.21%
Depreciation
28.00
113.00
-85.00
-75.22%
Profit Before Taxation & Exceptional Items
155.00
-75.00
230.00
306.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
155.00
-74.00
229.00
309.46%
Provision for Tax
37.00
3.00
34.00
1,133.33%
Profit After Tax
118.00
-77.00
195.00
253.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
286.00
764.00
-478.00
-62.57%
Profit Available for appropriations
404.00
690.00
-286.00
-41.45%
Appropriations
404.00
690.00
-286.00
-41.45%
Equity Dividend (%)
10%
10%
0.00
Earnings Per Share
2.2
-8.46
10.66
126.00%
Profit And Loss - Net Sales
Net Sales 1,811.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.17% vs 19.25% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 174.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.74% vs 99.44% in Mar 2024

Profit And Loss - Interest
Interest 8.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 124.86% vs 87.31% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 118.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 22.14% vs 149.82% in Mar 2024